Brief: GlaxoSmithKline’s 2017 Q1 Result
GlaxoSmithKline today released Unaudited Interim Financial Statements for the three months ended 31 March 2017.
Q1 2017| N3,850
Q1 2016| N4,152
(Loss)/Profit after tax N’million
Q1 2017| N-8
Q1 2016| N116
%age change| N/A
« Alert: Seplat Declares N5.9 Billion Loss (2017 Q1) Previous Post
Nairametrics is Nigeria's top business news and financial analysis website. We focus on providing resources that help small businesses and retail investors make better investing decisions. Nairametrics is updated daily by a team of professionals. Post updated as "Nairametrics" are published by our Editorial Board.